Given that Dementia and Schizophrenia  are the two most significant risk factors for severe COVID, it is important to note that the two diseases are intimately related to vasculitis. A search for a more satisfying model to explain aspects of schizophrenia uncovers clues pointing to genetically mediated CNS microvascular inflammatory disease. 

Let us also consider the case of a 75-year-old male presented to us with hemoptysis. Four months prior to current admission, he reported dyspnea upon exertion and was diagnosed with atrial fibrillation with rapid ventricular response for the first time. This patient was diagnosed with SILENT CORONARY VASCULITIS PRECEDING FULMINANT ANTI-NEUTROPHILIC CYTOPLASMIC ANTIBODY-ASSOCIATED PULMONARY-RENAL SYNDROME and returned to the ER FOUR MONTHS LATER WITH GROUND GLASS OPACITIES, as well as other hallmark symptoms of Severe COVID. 

Furthermore, there is the case of Lauren. Like any child, she suffered her fair share of bugs, including, at 13, glandular fever, but always bounced back. But, in October 2010, she picked up a chesty cough.

When her mother Adrienne took to get her checked out.

Within minutes of arriving at the hospital the next morning, the family was surrounded by a crash team, who told them Lauren had pneumonia.

Less than 48 hours later she had died.

Why is this relevant? Because, symptoms can come on quickly, or take up to eight weeks to appear. And then, they can be silent as the body slowly eats away at the linings of the blood vessels. 

There is evidence of de novo vascuilitis after M@dern@'a therapy (paper referenced). 

What is most concerning is that Vascuilitis is often silent and missed by GP's. Even before the advent of COVID, it is as common as meningitis, yet rarely looked for, and with devastating consequences.

The Spike Protein therapies must be immediately paused while patients are screened for vasculitis.

Referenced/Related Papers